U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Marketed Unapproved Drugs -- Compliance Policy Guide
  1. Regulatory Information

GUIDANCE DOCUMENT

Marketed Unapproved Drugs -- Compliance Policy Guide September 2011

Final

Marketed Unapproved Drugs -- Compliance Policy Guide

Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research

This Compliance Policy Guide (CPG) describes how we intend to exercise our enforcement discretion with regard to drugs marketed in the United States that do not have required FDA approval for marketing.


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Division of Dockets Management (HFA- 305)
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.